Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Calumet Inc (NASDAQ: CLMT) closed at $19.51 up 0.62% from its previous closing price of $19.39. In other words, the price has increased by $0.62 from its previous closing price. On the day, 0.74 million shares were traded. CLMT stock price reached its highest trading level at $19.79 during the session, while it also had its lowest trading level at $19.305.
Ratios:
For a deeper understanding of Calumet Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.62 and its Current Ratio is at 1.13.
Upgrades & Downgrades
In the most recent recommendation for this company, TD Cowen on November 11, 2025, Reiterated its Hold rating but revised its target price to $18 from $15 previously.
On May 13, 2025, BofA Securities started tracking the stock assigning a Buy rating and target price of $15.
UBS Upgraded its Sell to Neutral on March 17, 2025, whereas the target price for the stock was revised from $15 to $12.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 01 ’25 when DANIEL J SAJKOWSKI 2011 TRUST bought 2,000 shares for $15.76 per share.
Morical Gregory J sold 25,123 shares of CLMT for $419,303 on Jun 16 ’25. The SVP, GENERAL COUNSEL now owns 39,415 shares after completing the transaction at $16.69 per share. On Jun 16 ’25, another insider, Straumins Jennifer, who serves as the Director of the company, sold 100,000 shares for $16.23 each. As a result, the insider received 1,623,000 and left with 934,589 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLMT now has a Market Capitalization of 1692576768 and an Enterprise Value of 4146176768. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.42. Its current Enterprise Value per Revenue stands at 1.024 whereas that against EBITDA is 11.867.
Stock Price History:
The Beta on a monthly basis for CLMT is 1.23, which has changed by -0.049043655 over the last 52 weeks, in comparison to a change of 0.13329959 over the same period for the S&P500. Over the past 52 weeks, CLMT has reached a high of $23.75, while it has fallen to a 52-week low of $7.68. The 50-Day Moving Average of the stock is 1.41%, while the 200-Day Moving Average is calculated to be 24.42%.
Shares Statistics:
For the past three months, CLMT has traded an average of 718.13K shares per day and 612050 over the past ten days. A total of 86.75M shares are outstanding, with a floating share count of 67.41M. Insiders hold about 22.29% of the company’s shares, while institutions hold 52.53% stake in the company. Shares short for CLMT as of 1764288000 were 7914685 with a Short Ratio of 11.02, compared to 1761868800 on 8002271. Therefore, it implies a Short% of Shares Outstanding of 7914685 and a Short% of Float of 11.540000000000001.
Earnings Estimates
The market rating for Calumet Inc (CLMT) is a result of the insights provided by 1.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $0.01, with high estimates of $0.01 and low estimates of $0.01.
Analysts are recommending an EPS of between -$1.76 and -$1.76 for the fiscal current year, implying an average EPS of -$1.76. EPS for the following year is $0.41, with 1.0 analysts recommending between $0.41 and $0.41.
Revenue Estimates
A total of 5 analysts believe the company’s revenue will be $1.02B this quarter.It ranges from a high estimate of $1.18B to a low estimate of $798.2M. As of. The current estimate, Calumet Inc’s year-ago sales were $949.5MFor the next quarter, 5 analysts are estimating revenue of $1.04B. There is a high estimate of $1.12B for the next quarter, whereas the lowest estimate is $917.5M.
A total of 5 analysts have provided revenue estimates for CLMT’s current fiscal year. The highest revenue estimate was $4.28B, while the lowest revenue estimate was $3.9B, resulting in an average revenue estimate of $4.11B. In the same quarter a year ago, actual revenue was $4.19BBased on 6 analysts’ estimates, the company’s revenue will be $4.27B in the next fiscal year. The high estimate is $5.05B and the low estimate is $3.22B.
